Clinical Trials Directory

Trials / Completed

CompletedNCT05721586

Self-assembling Peptide With Sodium Fluoride in Treating White Spot Lesionss in Primary Teeth

Effectiveness of Self-assembling Peptide (p11-4) in Conjunction With Fluoride Varnish in the Management of White Spot Lesions in Primary Teeth (Randomized Controlled Clinical Trial)

Status
Completed
Phase
N/A
Study type
Interventional
Enrollment
24 (actual)
Sponsor
Hams Hamed Abdelrahman · Academic / Other
Sex
All
Age
3 Years – 6 Years
Healthy volunteers
Not accepted

Summary

Regenerative medicine-based approaches for caries treatment focus on biomimetic remineralization of initial carious lesions as a minimally invasive therapy using Self-Assembling Peptide P11-4 (CURODONTTM REPAIR) which enhances remineralization of white spot lesions (WSLs). The study aimed to assess clinically the effect of Self Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLOR) versus a 5% fluoride varnish (DURAFLOR) on remineralization of enamel White Spot Lesions in primary teeth.

Conditions

Interventions

TypeNameDescription
OTHERSelf Assembling Peptide P11-4 (CURODONTTM REPAIR) + Fluoride varnish (DURAFLORThe WSL was Acid etched with phosphoric acid gel 35-37% for 20 seconds, the tooth surface was rinsed with water and then dried afterwards application of CURODONTTM REPAIR
OTHERFluoride varnish (DURAFLORA very thin coat of the DURAFLOR varnish was applied by a thin brush which was then allowed to dry for 10 seconds. The varnish hardens on contact with saliva or moisture

Timeline

Start date
2020-06-01
Primary completion
2021-05-30
Completion
2021-05-30
First posted
2023-02-10
Last updated
2023-02-10

Locations

1 site across 1 country: Egypt

Source: ClinicalTrials.gov record NCT05721586. Inclusion in this directory is not an endorsement.